Ampio Pharmaceuticals Statistics
Want to see AMPE full AI Analyst Report?
Ampio Pharmaceuticals (AMPE) Stock Statistics & Valuation Metrics
Total Valuation
Ampio Pharmaceuticals has a market cap or net worth of $207.88K. The enterprise value is -$3.61T.
- Market Cap
- $207.88K
- Enterprise Value
- -$3.61T
Share Statistics
Ampio Pharmaceuticals has 1,135,358 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,135,358
- Owned by Insiders
- ―
- Owned by Institutions
- 0.04%
Financial Efficiency
Ampio Pharmaceuticals’s return on equity (ROE) is -2.57 and return on invested capital (ROIC) is -252.47%.
- Return on Equity (ROE)
- -2.57
- Return on Assets (ROA)
- -1.50
- Return on Invested Capital (ROIC)
- -252.47%
- Return on Capital Employed (ROCE)
- -2.83
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.44M
- Employee Count
- 6
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Ampio Pharmaceuticals is -0.02. Ampio Pharmaceuticals’s PEG ratio is -0.00.
- PE Ratio
- -0.02
- PS Ratio
- 0.00
- PB Ratio
- 0.04
- Price to FCF
- -0.02
- Price to Operating Cash Flow
- -0.02
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Ampio Pharmaceuticals had revenue of 0 and earned -8.63M in profits. Earnings per share was -10.67.
- Revenue
- 0
- Gross Profit
- -250.00K
- Operating Income
- -9.52M
- Pretax Income
- -8.63M
- Net Income
- -8.63M
- EBITDA
- -8.51M
- Earnings Per Share (EPS)
- -10.67
Cash Flow
In the last 12 months, operating cash flow was -8.56M and capital expenditures 0, giving a free cash flow of -8.56M billion.
- Operating Cash Flow
- -8.56M
- Free Cash Flow
- -8.56M
- Free Cash Flow per Share
- -10.59
Dividends & Yields
Ampio Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -4119.61%
- Earnings Yield
- -5827.40%
Stock Price Statistics
- Beta
- 42.76
- 52-Week Price Change
- 1730.00%
- 50-Day Moving Average
- 0.18
- 200-Day Moving Average
- 0.19
- Relative Strength Index (RSI)
- 47.40
- Average Volume (3m)
- ―
Important Dates
Ampio Pharmaceuticals upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- May 09, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Ampio Pharmaceuticals as a current ratio of 2.41, with Debt / Equity ratio of 8.15%
- Current Ratio
- 2.41
- Quick Ratio
- 2.41
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.46
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Ampio Pharmaceuticals has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Ampio Pharmaceuticals EV to EBITDA ratio is 0.42, with an EV/FCF ratio of 0.42.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.42
- EV to Free Cash Flow
- 0.42
- EV to Operating Cash Flow
- 0.42
Balance Sheet
Ampio Pharmaceuticals has $4.09M in cash and marketable securities with $274.00K in debt, giving a net cash position of $3.81M billion.
- Cash & Marketable Securities
- $4.09M
- Total Debt
- $274.00K
- Net Cash
- $3.81M
- Net Cash Per Share
- $3.36
- Tangible Book Value Per Share
- $4.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- ―
- AI Score
- 27
